PRLD

1.59

13.57% 0.19

Handel nachbörslich: 1.58 -0.01 -0.63%

Prelude Therapeutics Inc (PRLD)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$1.40

Offen:

$1.42

24-Stunden-Volumen:

798.94K

Relative Volume:

0.63

Marktkapitalisierung:

$99.96M

Einnahmen:

Nettoeinkommen (Verlust:

$-131.52M

KGV:

-0.8933

EPS:

-1.78

Netto-Cashflow:

$-107.56M

1W Leistung:

-5.36%

1M Leistung:

-1.85%

6M Leistung:

+79.42%

1J Leistung:

+64.90%

1-Tages-Spanne:

$1.32

$1.60

1-Wochen-Bereich:

$1.32

$1.70

52-Wochen-Spanne:

$0.6101

$4.22

Prelude Therapeutics Inc Stock (PRLD) Company Profile

Firmenname

Prelude Therapeutics Inc

Sektor

Healthcare (1134)

Branche

Biotechnology (635)

Telefon

(302) 467-1280

Adresse

175 INNOVATION BOULEVARD, WILMINGTON

Mitarbeiter

131

Twitter

Nächster Verdiensttermin

2024-10-30

Neueste SEC-Einreichungen

PRLD's Discussions on Twitter

Vergleichen Sie PRLD mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
PRLD Prelude Therapeutics Inc	1.59	88.01M	0	-131.52M	-107.56M	-1.78
VRTX Vertex Pharmaceuticals Inc	429.82	107.58B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	787.32	80.03B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	429.80	57.37B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	917.93	55.83B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	209.02	44.13B	447.02M	-1.18B	-906.14M	-6.1812

Prelude Therapeutics Inc Stock (PRLD) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-09-19	Hochstufung	H.C. Wainwright	Neutral → Buy
2024-06-20	Herabstufung	Barclays	Equal Weight → Underweight
2024-03-13	Eingeleitet	JMP Securities	Mkt Outperform
2024-02-20	Herabstufung	H.C. Wainwright	Buy → Neutral
2023-12-19	Herabstufung	Morgan Stanley	Equal-Weight → Underweight
2022-11-21	Herabstufung	BofA Securities	Neutral → Underperform
2022-09-09	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2022-07-29	Eingeleitet	Jefferies	Buy
2022-03-15	Herabstufung	BofA Securities	Buy → Neutral
2022-02-28	Herabstufung	Barclays	Overweight → Equal Weight
2021-10-08	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2021-07-27	Hochstufung	BofA Securities	Neutral → Buy
2021-04-26	Eingeleitet	H.C. Wainwright	Buy
2021-03-09	Eingeleitet	Barclays	Overweight
2020-11-20	Herabstufung	BofA Securities	Buy → Neutral
2020-10-20	Eingeleitet	BofA Securities	Buy
2020-10-20	Eingeleitet	Goldman	Neutral
2020-10-20	Eingeleitet	Morgan Stanley	Equal-Weight

Alle ansehen

Prelude Therapeutics Inc Aktie (PRLD) Neueste Nachrichten

07:08 AM

This trade activity should not be overlooked: Prelude Therapeutics Inc (PRLD) - Setenews

07:08 AM

Nov 21, 2025

Prelude Therapeutics Experiences Revision in Its Stock Evaluation Amid Mixed Financial Trends - Markets Mojo

Nov 21, 2025

Nov 20, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prelude Therapeutics IncorporatedPRLD - PR Newswire

Nov 20, 2025

Nov 19, 2025

Will Prelude Therapeutics Incorporated stock outperform Dow Jones indexJuly 2025 Sentiment & Smart Money Movement Alerts - newser.com

Nov 19, 2025

Is Prelude Therapeutics Incorporated stock supported by innovation pipeline2025 Volume Leaders & Free High Return Stock Watch Alerts - newser.com

Nov 19, 2025

PRLD Investors Have Opportunity to Join Prelude Therapeutics Incorporated Fraud Investigation ... - Bakersfield.com

Nov 19, 2025

PRLD Investors Have Opportunity to Join Prelude - GlobeNewswire

Nov 19, 2025

What to do if you’re stuck in Prelude Therapeutics IncorporatedPortfolio Update Summary & Smart Investment Allocation Insights - newser.com

Nov 19, 2025

Is Prelude Therapeutics Incorporated stock ready for a breakoutJuly 2025 Sector Moves & Weekly Market Pulse Updates - newser.com

Nov 19, 2025

What sentiment indicators say about Prelude Therapeutics Incorporated stock2025 Valuation Update & Safe Capital Growth Stock Tips - newser.com

Nov 19, 2025

Prelude Advances Two Novel Cancer Programs as Cash Runway Extends Into 2027 - MyChesCo

Nov 19, 2025

Nov 18, 2025

Order flow analysis tools used on Prelude Therapeutics IncorporatedJuly 2025 Sector Moves & Daily Volume Surge Signals - newser.com

Nov 18, 2025

Nov 17, 2025

Can Prelude Therapeutics Incorporated stock hit analyst price targets2025 Geopolitical Influence & Fast Entry Momentum Trade Alerts - newser.com

Nov 17, 2025

Real time alert setup for Prelude Therapeutics Incorporated performanceProduct Launch & Safe Entry Trade Signal Reports - newser.com

Nov 17, 2025

Is Prelude Therapeutics Incorporated stock supported by strong fundamentalsJuly 2025 Market Mood & Weekly Breakout Stock Alerts - newser.com

Nov 17, 2025

Century Therapeutics Unveils iPSC Beta Islet Program as Cash Runway Extends Into 2027 - MyChesCo

Nov 17, 2025

Using flow based indicators on Prelude Therapeutics Incorporated2025 Market Sentiment & Fast Moving Trade Plans - newser.com

Nov 17, 2025

Taking on analysts’ expectations and winning: Prelude Therapeutics Inc (PRLD) - Setenews

Nov 17, 2025

Prelude Therapeutics’ Earnings Call Highlights Strategic Moves and Challenges - MSN

Nov 17, 2025

Nov 16, 2025

Published on: 2025-11-16 22:10:23 - newser.com

Nov 16, 2025

What institutional flow reveals about Prelude Therapeutics IncorporatedJuly 2025 Earnings & Safe Capital Growth Tips - newser.com

Nov 16, 2025

Is Prelude Therapeutics Incorporated stock a defensive play in 2025Weekly Risk Summary & Daily Oversold Bounce Ideas - newser.com

Nov 16, 2025

How to build a custom watchlist for Prelude Therapeutics IncorporatedJuly 2025 Fed Impact & Fast Entry High Yield Stock Tips - newser.com

Nov 16, 2025

Pattern recognition hints at Prelude Therapeutics Incorporated upsideSwing Trade & Advanced Technical Analysis Signals - newser.com

Nov 16, 2025

Nov 15, 2025

How moving averages guide Prelude Therapeutics Incorporated tradingBuy Signal & Weekly Breakout Watchlists - newser.com

Nov 15, 2025

Can Prelude Therapeutics Incorporated stock sustain free cash flow growthJuly 2025 Price Swings & Community Trade Idea Sharing Platform - newser.com

Nov 15, 2025

Nov 14, 2025

Volume spikes in Prelude Therapeutics Incorporated stock – what they meanMarket Performance Report & Daily Stock Momentum Reports - newser.com

Nov 14, 2025

Prelude Therapeutics Incorporated (NASDAQ:PRLD) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 14, 2025

Will Prelude Therapeutics Incorporated stock deliver shareholder valueTrade Exit Summary & AI Forecast for Swing Trade Picks - newser.com

Nov 14, 2025

Prelude Therapeutics stock rating reiterated at Market Outperform by Citizens - Investing.com Canada

Nov 14, 2025

Published on: 2025-11-14 02:04:28 - newser.com

Nov 14, 2025

Nov 13, 2025

Prelude Therapeutics Advances Pipeline and Strengthens Financials - TipRanks

Nov 13, 2025

Nov 12, 2025

Transcript : Prelude Therapeutics Incorporated, Q3 2025 Earnings Call, Nov 12, 2025 - MarketScreener

Nov 12, 2025

Can Prelude Therapeutics Incorporated stock maintain operating margins2025 Key Lessons & Expert Approved Momentum Trade Ideas - newser.com

Nov 12, 2025